Skip to main content
. 2020 Jun 10;15(1):447–456. doi: 10.1515/med-2020-0110

Figure 2.

Figure 2

(a) A forest graph showing the pooled effect sizes of ORR (ES; effect size with 95% CI) with regards to the percentage of patients with prior therapy. (b) A forest graph showing the pooled effect sizes of ORR (ES; effect size with 95% CI) with regards to the combination of pembrolizumab treatment.